Recursion REC-994 Phase 2 Trial - Dr. Lisa Boyette, Senior Director of Medical Affairs
1:00:44
Introducing Ovid & Graviton's New ROCK2 Inhibitor for CCM
33:53
Download Day 2024 — Recursion's Clinical Programs (David Mauro, Chief Medical Officer)
51:47
Sebastián La Rosa, medico especialista en longevidad; +Entrevistas con Luis Novaresio
1:02:57
Big Picture Updates on Guidelines, Trials and Biomarkers
59:18
Delaney Fisher Ph.D. Focused Ultrasound Update Webinar
1:12:49
Probióticos, piel y sistema inmune: medicina del futuro | Dr. John Gaviria
17:56
Download Day 2024 — State of Recursion (Chris Gibson, Recursion Co-founder & CEO)
16:18